4-{5-[4-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl}pyridine
Structure Info
- Chemspace ID
- CSSB00104232019 (In-Stock Building Blocks)
- MFCD
- MFCD05883813
- IUPAC Name
- 4-{5-[4-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl}pyridine
- Mol formula
- C14H8F3N3O
- Mol weight
- 291 Da
- Catalog Number(s)
- AA001I5Z, AA70099, AP-501/43160613, CSC077555800, CSC104232019, CSCR00077555800, JH634971, ST001JPJ, TX001JEF, Z50148364
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 2.66
- Heavy atoms count
- 21
- Rotatable bond count
- 3
- Number of rings
- 3
- Carbon bond saturation, Fsp3
- 0.071
- Polar surface area (Å)
- 52
- Hydrogen bond acceptors count
- 3
- Hydrogen bond donors count
- 0
![Chemical structure of 4-{5-[4-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl}pyridine (C14H8F3N3O) - CSSB00104232019](/st/structure/200/f36c8f033222f2bb465a3577d2ca8ff3/FC%2528F%2529%2528F%2529C1%253DCC%253DC%2528C%253DC1%2529C1%253DNN%253DC%2528O1%2529C1%253DCC%253DNC%253DC1.png "C14H8F3N3O")
- Zoom the structure
- CSSB00104232019
Items Overall 3 items from 3 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| AA Blocks CN | 12 days | China To: | 90 | 10 mg | 336.60 | |
Description: CAS: 143703-84-8 | ||||||
| 1st Scientific CN | 14 days | China To: | 90 | 10 mg | 245.30 | |
Description: Pyridine, 4-[5-[4-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl]-; CAS: 143703-84-8 | ||||||
| 1st Scientific LLC | 14 days | United States To: | 90 | 10 mg | 245.30 | |
Description: Pyridine, 4-[5-[4-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl]-; CAS: 143703-84-8 | ||||||
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Similarity Analogs
![Chemical structure of 2-phenyl-5-[4-(trifluoromethyl)phenyl]-1,3,4-oxadiazole - CSSB00104232017](/st/structure/200/013aa98bdae90da71d63619f2112f2f9/FC%2528F%2529%2528F%2529C1%253DCC%253DC%2528C%253DC1%2529C1%253DNN%253DC%2528O1%2529C1%253DCC%253DCC%253DC1.png)
![Chemical structure of 5-[4-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-amine - CSSB00000298755](/st/structure/200/a5a2db30825b6af2ca37efba9872d420/NC1%253DNN%253DC%2528O1%2529C1%253DCC%253DC%2528C%253DC1%2529C%2528F%2529%2528F%2529F.png)
![Chemical structure of 4-[5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl]pyridine - CSSB00102587592](/st/structure/200/d41bd65523b496b09c25381c19716223/O1C%2528%253DNN%253DC1C1%253DCC%253DNC%253DC1%2529C1%253DCC%253DNC%253DC1.png)
![Chemical structure of 2-methyl-5-[4-(trifluoromethyl)phenyl]-1,3,4-oxadiazole - CSSB00010271569](/st/structure/200/556726781f997772d0c7518b2f3d12a7/CC1%253DNN%253DC%2528O1%2529C1%253DCC%253DC%2528C%253DC1%2529C%2528F%2529%2528F%2529F.png)
![Chemical structure of 5-[4-(trifluoromethyl)phenyl]-1,3,4-oxadiazole-2-carbaldehyde - CSSB03496527673](/st/structure/200/e1387e349224201dbbf10875eb5bcbba/FC%2528F%2529%2528F%2529C1%253DCC%253DC%2528C%253DC1%2529C1%253DNN%253DC%2528O1%2529C%253DO.png)
![Chemical structure of 4-[4-(trifluoromethyl)benzoyl]pyridine - CSSB00001009736](/st/structure/200/7adac6810fbe6836d99dfac5442f87e2/FC%2528F%2529%2528F%2529C1%253DCC%253DC%2528C%253DC1%2529C%2528%253DO%2529C1%253DCC%253DNC%253DC1.png)
